BUSINESS● LOW1h ago · Sep 3, 2026, 8:53 AM
HUTCHMED jumps 15% after licensing cancer therapy to GSK for up to $1.295B
Seeking Alpha Tech · global
No summary available — read the full story at the source.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESS14m agoAs hordes head to Shenzhen, Hong Kong bars, restaurants sign up for more floor spaceSouth China Morning PostBUSINESS15m agoYen jumps to one-month high as traders weigh chance of further interventionCNBCBUSINESS17m agoEnQuest is interested in buying BP’s North Sea assets, CEO tells CNBCCNBCBUSINESS25m agoNARTO Credits Fuel Subsidy Removal, Local Refining For Sustained Naira StabilityChannels TV